Most Recent Guidances (All Agencies)
- FDA proposes draft guidelines intended to improve the representation of women in medical device clinical studies
- S2 R1
- Good Laboratory Practice for Nonclinical Laboratory Studies
- Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination
- Investigational New Drug Applications (INDs)— Determining Whether Human Research Studies Can Be Conducted Without an IND


